Skip to main content
. Author manuscript; available in PMC: 2020 Aug 8.
Published in final edited form as: Nature. 2015 Jan 7;517(7535):455–459. doi: 10.1038/nature14098

Table 1 |.

Activity of teixobactin against pathogenic microorganisms

Organism and genotype Teixobactin MIC(μg ml−1)
S. aureus (MSSA) 0.25
S. aureus + 10% serum 0.25
S. aureus (MRSA) 0.25
Enterococcus faecalis (VRE) 0.5
Enterococcus faecium (VRE) 0.5
Streptococcus pneumoniae (penicillinR) ≤ 0.03
Streptococcus pyogenes 0.06
Streptococcus agalactiae 0.12
Viridans group streptococci 0.12
B. anthracis ≤ 0.06
Clostridium difficile 0.005
Propionibacterium acnes 0.08
M. tuberculosis H37Rv 0.125
Haemophilus influenzae 4
Moraxella catarrhalis 2
Escherichia coli 25
Escherichia coli (asmB1) 2.5
Pseudomonas aeruginosa >32
Klebsiella pneumoniae >32

The MIC was determined by broth microdilution. MSSA, methicillin-sensitive S. aureus; VRE, vancomycin-resistant enterococci.

HHS Vulnerability Disclosure